BAYRY's Kerendia Label Expansion Application Gets Priority Review
21/5 19:00
Bayer wins FDA Priority Review for Kerendia label expansion in CKD tied to type I diabetes after strong phase III data....
21/5 19:00
Bayer wins FDA Priority Review for Kerendia label expansion in CKD tied to type I diabetes after strong phase III data....